COMPANY PROFILE

MediLink-Global

Explore full profile

Medical Third Party Administration (TPA) services & Solutions

Dongcheng District, ChinaFounded 2001Health

Valuation $100–250M Last recorded · 2021

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About MediLink-Global

MediLink-Global, established in 2005, is a prominent health management service platform in China. The company provides a whole-life-cycle health management service, which includes personalized and high-quality medical and health services for high-end health insurance customers and high-net-worth families.

MediLink-Global also operates as a regional Medical Claim & Benefit Management Solution provider and Third-Party Administrator (TPA). The company has a vast network of 1.4 million domestic and foreign medical resources and collaborates with over 40 insurance companies. It has served more than 150,000 global members. The company's services are accessible through its health service appointment platform.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2001
Headquarters: Dongcheng District, China
Employees: 46
Open positions: 8
Dealroom signal: 73.8/100
Industry: Health
Sector: Health, Hard Tech
Business model: Marketplace & ecommerce
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Mar 2021	$33M	$132M	Qiming Venture Partners	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

MediLink-Global website traffic

Latest recorded traffic for MediLink-Global is 2.5K monthly website visits, up 25% over the last three months. MediLink-Global's team grew 4.5% over the past year.

Latest monthly visits2.5K 3-month web change+25% 1-year team growth+4.5%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

AMShanghai, Shanghai, China · Other · Jul 11, 2026 java/Shanghai, Shanghai, China · Backend Development · Jul 10, 2026 BD+Shanghai, Shanghai, China · Other · Jun 20, 2026 +Nanjing, Jiangsu, China · Other · Jun 12, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FIFibroBiologicsDeveloping therapies using fibroblasts, which are a type of cell that is found in connective tissue	Houston, United States	Operational	14	$103M	$253M
OBOcelot BioBiotech & Life Sciences	San Diego, United States	Operational
1T101 TherapeuticsDeveloping the first targeted glucocorticoid with all of the potency of steroids but none of the systemic toxicities	Tel Aviv-Yafo, Israel	Operational
CICianatxInnovative therapies for Diabetic Retinopathy, preventing vision loss and blindness with novel treatments	Annapolis, United States	Operational
APAculys PharmaCommitted to the patient experience including the awareness, screening, diagnosis, treatment of disease and the resolution of surrounding social issues for patients and their families confronted with neurological and psychiatric disease	Fujisawa, Japan	Acquired
BIBiofronteraSpecializing in dermatological products commercializing a portfolio of dermatological drugs specializing on the fields of photodynamic therapy (PDT) and topical antibiotics	Woburn, United States	Operational
EBEucure BiopharmaInnovative immuno-oncology targeted antibodies advancing through clinical trials	Guangzhou, China	Operational
ETElastrin TherapeuticsReversing diseases by targeting damaged elastin fibers	Simpsonville, United States	Operational